High frequency of CD4+CXCR5+ TFH cells in patients with immune-active chronic hepatitis B

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Feng, Junyan ^a   Lu, Lu ^a   Hua, Cong ^a   Qin, Ling ^a   Zhao, Pingwei ^a   Wang, Juan ^a   Wang, Ye ^a   Li, Wanyu ^a   Shi, Xiaodong ^a   Jiang, Yanfang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD4 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENINE; ANTIVIRUS AGENT; CXCR5 PROTEIN, HUMAN; CYTOKINE; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; LIVER CELL; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SPLEEN CELL; T FOLLICULAR HELPER CELL; TRANSGENIC MOUSE; VIRUS LOAD; WILD TYPE; ADAPTIVE IMMUNITY; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

HEPATITIS B VIRUS; MUS MUSCULUS;

ADAPTIVE IMMUNITY; ADENINE; ADULT; ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD4; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; CYTOKINES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; PHOSPHONIC ACIDS; RECEPTORS, CXCR5; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 79960065741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021698     Document Type: Article

References (30)

1. Wang FS, Xing LH, Liu MX, Zhu CL, Liu HG, et al. (2001) Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7: 537-541.
2. Bertoletti A, Gehring AJ, (2006) The immune response during hepatitis B virus infection. J Gen Virol 87: 1439-1449.
3. Pol S, (2006) Natural history of hepatitis B infection. Presse Med 35: 308-316.
4. Baumert TF, Thimme R, von Weizsäcker F, (2007) Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13: 82-90.
5. Lai CL, Yuen MF, (2007) The natural history of chronic hepatitis B. J Viral Hepat 14: 6-10.
6. Rehermann B, Nascimbeni M, (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
7. Pan CQ, Zhang JX, (2005) Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2: 36-40.
8. Ganem D, Prince AM, (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129.
9. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, et al. (2005) Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatol 41: 771-778.
10. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, et al. (2005) Modulation of the CD8+-T-cell response by CD4+CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 79: 3322-3328.
11. Pesu M, (2010) T-helper cells-bandleaders of immune response. Duodecim 126: 2179-2187.
12. Huang X, Reynolds AD, Mosley RL, Gendelman HE, (2009) CD 4+ T cells in the pathobiology of neurodegenerative disorders. J Neuroimmunol 211: 3-15.
13. Pelletier N, McHeyzer-Williams LJ, Wong KA, Urich E, Fazilleau N, et al. (2010) Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol 11: 1110-1118.
14. Laurent C, Fazilleau N, Brousset P, (2010) A novel subset of T-helper cells: follicular T-helper cells and their markers. Haematologica 95: 356-358.
15. Linterman MA, Vinuesa CG, (2010) Signals that influence T follicular helper cell differentiation and function. Semin Immunopathol 32: 183-196.
16. Zhang CM, Zhang B, Zhang Y, Xu ZW, Yang K, et al. (2009) Identification of human follicular helper T cells in peripheral blood by flow cytometry. Chin J Cell Mol Immunol 25: 1063-1064.
17. Rodríguez-Pinilla SM, Atienza L, Murillo C, Perez-Rodriguez A, Montes-Moreno S, et al. (2008) Peripheral T-cell Lymphoma With Follicular T-cell Markers. Am J Surg Pathol 32: 1787-1799.
18. Rodríguez Pinilla SM, Roncador G, Rodríguez-Peralto JL, Mollejo M, García JF, et al. (2009) Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell. Markers. Am J Surg Pathol 33: 81-90.
19. Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, et al. (2010) Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 62: 234-244.
20. Ye P, Weng ZH, Zhang SL, Zhang JA, Zhao L, et al. (2008) Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol 14: 4551-4557.
21. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
22. Jiang YF, Ma ZH, Xin GJ, Yan HQ, Li WY, et al. (2010) Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm 2010: 143026.
23. Jiang YF, Li W, Yu L, Liu JJ, Xin GJ, et al. (2010) Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol 8: 75-82.
24. Yim HJ, Lok AS, (2006) Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43: S173-181.
25. Zhang Z, Zhang S, Zou Z, Shi J, Zhao J, et al. (2011) Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatol 53: 73-85.
26. Li A, Yuan Q, Huang Z, Fan J, Guo R, et al. (2010) Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol 17 (3): 464-469.
27. Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD, (2010) Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob Agents Chemother 54: 749-756.
28. Chen Y, Wei H, Sun R, Dong Z, Zhang J, et al. (2007) Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46 (3): 706-715.
29. Morgan E, Varro R, Sepulveda H, et al. (2004) Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110: 252-266.
30. Tarnok A, Hambsch J, Chen R, Varro R, (2003) Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin Chem 49: 1000-1002.